ArticlePharmaceutical biology2021

Aucubin slows the development of osteoporosis by inhibiting osteoclast differentiation via the nuclear factor erythroid 2-related factor 2-mediated antioxidation pathway.

Yongfeng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.